News

Filter news by
German cardiac center putting the Myosuit to the test
Zurich/Berlin - The German Heart Institute Berlin is the first organization in the world to investigate the benefits of the Myosuit for heart failure patients. The researchers hope that it will lead t...
W.A. de Vigier Foundation awards start-ups
Solothurn - The W.A. de Vigier Foundation has given awards to six start-ups, three of which come from the Greater Zurich Area. They convinced the foundation with sustainable clothing, intelligent ligh...
New consortium with pharmaceutical giants
Schlieren ZH - InSphero is joining forces with companies such as Pfizer, Sanofi and Genentech. The partners plan to better investigate the potential negative effects of new medicinal products on the l...
Westhive expanding in Greater Zurich Area
Zurich/Zug – Zurich-based coworking space provider Westhive intends to open a new site in the Tech Cluster Zug in summer 2022. Here, it will offer flexible workspace and conference rooms. A coffee bar...
Agire Foundation creates innovation platform for SMEs
Manno TI – The Agire Foundation has launched a new online platform, Scouting Days Agire. This enables SMEs from the Italian-speaking part of Switzerland to start a “call for innovation” to find invent...
Roambee acquires Modum
Zurich/Santa Clara - Modum, the specialist in last mile-focused cold chain monitoring, has been taken over by Roambee. With this acquisition, the Silicon Valley logistics firm intends to expand its of...
Sygnum expands decentralized finance token portfolio
Zurich - Sygnum is launching regulated banking services for various kinds of decentralized finance tokens. In this sense, the crypto bank is aiming to build a bridge between digital and conventional f...
Researchers keeping track of viral evolution
Zurich – Researchers at the Swiss Federal Institute of Technology in Zurich have been successful in their attempts to mimic a decisive step in the evolution of viruses: the formation of a structure th...
Therapy discovered to combat COVID-19 and flu
Zurich - Inflamed pharma, a project enterprise of Xlife Sciences, has discovered an active ingredient that is able to reduce viral load by up to 90 percent in coronavirus patients and those suffering ...

Contact us

Can we put you in touch with a peer company or research institute? Do you need any information regarding your strategic expansion to Switzerland's technology and business center?  
info@greaterzuricharea.com